Lowe ER[au] - Search Results

Year	Number of Results
1958	1
1997	1
2002	2
2003	3
2004	2
2005	5
2006	2
2007	3
2008	2
2009	1
2010	1
2011	2
2019	1
2022	0

1

Proteolytic degradation of nitric oxide synthase: effect of inhibitors and role of hsp90-based chaperones.

Osawa Y, Lowe ER, Everett AC, Dunbar AY, Billecke SS. Osawa Y, et al. Among authors: lowe er. J Pharmacol Exp Ther. 2003 Feb;304(2):493-7. doi: 10.1124/jpet.102.035055. J Pharmacol Exp Ther. 2003. PMID: 12538799 Review.

2

Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38.

Cavet ME, Glogowski S, Lowe ER, Phillips E. Cavet ME, et al. Among authors: lowe er. J Ocul Pharmacol Ther. 2019 Jun;35(5):291-300. doi: 10.1089/jop.2018.0136. Epub 2019 Mar 23. J Ocul Pharmacol Ther. 2019. PMID: 30907685 Free PMC article.

3

In vitro metabolism, glutathione conjugation, and CYP isoform specificity of epoxidation of 4-vinylphenol.

Zhang F, Lowe ER, Rick DL, Qiu X, Leibold E, Cruzan G, Bartels MJ. Zhang F, et al. Among authors: lowe er. Xenobiotica. 2011 Jan;41(1):6-23. doi: 10.3109/00498254.2010.523735. Epub 2010 Oct 7. Xenobiotica. 2011. PMID: 20925585

4

Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys.

Proksch JW, Lowe ER, Ward KW. Proksch JW, et al. Among authors: lowe er. Drug Metab Dispos. 2011 Jul;39(7):1181-7. doi: 10.1124/dmd.111.039099. Epub 2011 Mar 25. Drug Metab Dispos. 2011. PMID: 21441467

5

Naturally occurring neuronal NO-synthase inactivators found in Nicotiana tabacum (Solanaceae) and other plants.

Lowe ER, Everett AC, Lau M, Dunbar AY, Michener D, Osawa Y. Lowe ER, et al. Phytomedicine. 2007 May;14(5):344-52. doi: 10.1016/j.phymed.2006.09.004. Epub 2006 Nov 3. Phytomedicine. 2007. PMID: 17084601

6

Tetrahydrobiopterin protects against guanabenz-mediated inhibition of neuronal nitric-oxide synthase in vitro and in vivo.

Dunbar AY, Jenkins GJ, Jianmongkol S, Nakatsuka M, Lowe ER, Lau M, Osawa Y. Dunbar AY, et al. Among authors: lowe er. Drug Metab Dispos. 2006 Sep;34(9):1448-56. doi: 10.1124/dmd.106.009951. Epub 2006 May 31. Drug Metab Dispos. 2006. PMID: 16738031

7

The effect of plasma lipids on the pharmacokinetics of chlorpyrifos and the impact on interpretation of blood biomonitoring data.

Lowe ER, Poet TS, Rick DL, Marty MS, Mattsson JL, Timchalk C, Bartels MJ. Lowe ER, et al. Toxicol Sci. 2009 Apr;108(2):258-72. doi: 10.1093/toxsci/kfp034. Epub 2009 Feb 17. Toxicol Sci. 2009. PMID: 19223661

8

Investigations of oxidative stress, antioxidant response, and protein binding in chlorpyrifos exposed rat neuronal PC12 cells.

Geter DR, Kan HL, Lowe ER, Rick DL, Charles GD, Gollapudi BB, Mattsson JL. Geter DR, et al. Among authors: lowe er. Toxicol Mech Methods. 2008;18(1):17-23. doi: 10.1080/15376510701389530. Toxicol Mech Methods. 2008. PMID: 20020887

9

Metabolism-based inactivation of neuronal nitric-oxide synthase by components of cigarette and cigarette smoke.

Demady DR, Lowe ER, Everett AC, Billecke SS, Kamada Y, Dunbar AY, Osawa Y. Demady DR, et al. Among authors: lowe er. Drug Metab Dispos. 2003 Jul;31(7):932-7. doi: 10.1124/dmd.31.7.932. Drug Metab Dispos. 2003. PMID: 12814971

10

The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/hsp70-based chaperone system in vivo where it acts to stabilize the client protein: hsp90 complex.

Morishima Y, Kanelakis KC, Murphy PJ, Lowe ER, Jenkins GJ, Osawa Y, Sunahara RK, Pratt WB. Morishima Y, et al. Among authors: lowe er. J Biol Chem. 2003 Dec 5;278(49):48754-63. doi: 10.1074/jbc.M309814200. Epub 2003 Sep 24. J Biol Chem. 2003. PMID: 14507910 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results